Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0169224 A1

Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0169224 A1

US 20190169224A1 ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2019 /0169224 A1 CAVANAGH et al. (43 ) Pub . Date : Jun . 6 . 2019 ( 54 ) PREPARATIONS OF HYDROPHOBIC 487, filed on Aug. 23 , 2012 , provisional application THERAPEUTIC AGENTS , METHODS OF No . 61 /763 ,770 , filed on Feb . 12 , 2013 , provisional MANUFACTURE AND USE THEREOF application No . 61/ 788 ,519 , filed on Mar. 15 , 2013 . (71 ) Applicant: NICOX OPHTHALMICS, INC. , Fort Worth , TX (US ) Publication Classification ( 72 ) Inventors : Thomas CAVANAGH , New Canaan , (51 ) Int. CI. CT (US ) ; Shikha P . Barman , Bedford , C07 ) 7700 (2006 . 01) MA (US ) ; Tian Hao , Acton , MA (US ) ; C07 ) 71 /00 ( 2006 . 01 ) Thomas B . Leland, Bolton , MA (US ) ; C07J 3 /00 ( 2006 .01 ) Ritesh V . Thekkedath , Dombivli ( E ) . C07 ) 31 /00 (2006 . 01) M . S . ( IN ) (52 ) U . S . CI. CPC C07J 77009 ( 2013 .01 ) ; C07J 71 /0031 ( 2013 . 01 ) ; C07J 3 /005 ( 2013 .01 ) ; Y10T ( 21 ) Appl. No. : 16 / 203, 324 428 / 2982 (2015 . 01 ) ; C07J 71/ 0005 ( 2013 .01 ) ; ( 22 ) Filed : Nov . 28 , 2018 CO7B 2200 /13 ( 2013. 01 ) ; C07J 31/ 006 Related U . S . Application Data ( 2013 .01 ) (63 ) Continuation of application No. 15 / 660 ,470 , filed on (57 ) ABSTRACT Jul. 26 , 2017 , now Pat. No . 10 , 174 ,071 , which is a continuation of application No . 14 /399 ,780 , filed on The present invention further provides method of preparing Nov . 7 , 2014 , now Pat . No . 9 , 822, 142, filed as appli nanocrystals of a hydrophobic therapeutic agent such as cation No . PCT/ US2013 /039694 on May 6 , 2013 , fluticasone or triamcinolone , pharmaceutical compositions which is a continuation of application No . 13 / 735 , ( e . g ., topical or intranasal compositions ) thereof and meth 973 , filed on Jan . 7 , 2013 , now Pat. No . 8 , 765 ,725 . ods for treating and / or preventing the signs and / or symptoms (60 ) Provisional application No . 61/ 644 , 105 , filed on May of disorders such as blepharitis , meibomian gland dysfunc 8 , 2012 , provisional application No . 61 /657 ,239 , filed tion or skin inflammation or a respiratory disease ( e . g . , on Jun . 8 , 2012 , provisional application No . 61 /692 , asthma) . Patent Application Publication Jun . 6 , 2019 Sheet 1 of 42 US 2019 / 0169224 A1 . : . 2 . ChemicalStructureofFluticasonePropionate FIG.1 w wwwwwwwwwwwwww .. : Physico-ChemicalCharacteristicsofFluticasonePropionate : 272-273C(DSC/TGA) afterrightDecomposes 7. 7 500.57Daltons : |240nm 14.48 melting NO IandII Case * * * * * * EL * * * * * * * * * * * ATA : : S KINYARWANA VIEWS MeltingPoint PointDecompositionAAA Polymorphicforms MolecularFormula ???? d60 Properties APlimax M.W pka Photolabile Patent Application Publication Jun . 6 , 2019 Sheet 2 of 42 US 2019 / 0169224 A1 Impurity 12min 11 Impurity 10 eerecer Baselineexpansionofimpurities ranv rei 199.63 9 16.80450098 35.56320:21 *.PASAP 17070. FluticasonePropionateanditsimpuritiesB,CD Impurity mesmo menit u n pocoRin * * whommes h wit . MAU Y 2.FIG 15min .66 0.72 ht ., . .???????????????????????????????????????- 14 1 . 0 13 . .2 8 12 10.4 14. 59. 4 11 HPLCofFluticasonePropionateanditsimpurities 99?."??????07???????>?????????,????????- 10 9 De FPS 8 7 . N O . 2 . 1 . - - . AN . 1 MAU 700 Patent Application Publication Jun . 6 , 2019 Sheet 3 of 42 US 2019 / 0169224 A1 FilingLine Addfinalexcipienis(optional) i ? conc.desiredconcentrateto1933 TangentialFlow NY Purify,addvehicleand . LE FIG.3 febrero (BatchProcess)0000000 Undersecondtemp.,e25°C PhaseII) PhaseIII Erse (Phase 00 Soose min/mi.41-50:rateowH Stenle-filtered Underfirsttemp.,294°C X Generationofnano-crystals 74 % DissolveFPandsterilefilter fpDissolved insterile SVILES w XXXX Patent Application Publication Jun . 6 , 2019 Sheet 4 of 42 US 2019 / 0169224 A1 Addotherexcipients(optional) FillingLinew Por. D W WHAT AW :. x codes Xu MW Rui (8.9,TFForhollowfibercartridge) WON PurificationApparatus ** * CE N 20 - 5 FIG.4 Annealing/HoldTank Undersecondtemp.,6925°C ProcessofNanocrystalProductionandPurification CAD OUT Underfirsttemp. * TI ter 99 % Stenle PATRODAL Patent Application Publication Jun . 6 , 2019 Sheet 5 01of 4242 US 2019 / 0169224 A1 1.' 0.512405913 . )cp15 (MC %25 .A0 /BAK %12 .0 2.91 )cp15 ( MC %25 .0/ BAK %12 .0 X) cm15 ( MC %25 .0 /BAK %12 .0 1.376XD ...% 50 . 0 /PVA %70 .0/ BAKourth Att %13 .0 Tema146 water/)cp 4000 (HPMC %51. 0 /BAK %15 .0 0.641418631 * * * * Water/Tween80 % 86 .1/ PVA %38 .1 doooos Frie water/CMC %5. 0/ 80 Tween %2 FIG.5 water/CMC %5 .0/ Tween80 %2 *water /CMC %5 .0/ 80 Tween %2 ParticlesizeofFPnanocrystalbatches 1113 H * * * * waterwater/CMC/ Gum %9Xanthan. 0/ 80 Tween% 5. 0/ 80 % 2 Tween % 2 soooooo * * ** * water/CMC %9 .0/ 80 Tween %2 Water/CMCBAK %%365 ..01 / Tween60 %9 .0 water/Tween20 %58 .0 water/Tween20 a% 8. 0 microns in Size Patent Application Publication Jun . 6 , 2019 Sheet 6 of 42 US 2019 / 0169224 A1 * . ooo risurrecce . ** * 1992. SYA WN 5000 . * * * AW 9 : 00 * 2. ** CA * V . AVXXXXX YENT XXX LUX IVACY w 123456789101112131415161718192021222324252627282930 Particlesizeofbatchesobtainedby“top-down"particle2 BATCH# FIG.6 reductiontechniques Microfluidization $Ultrasound uopjezusiowohu OS 7 :17 2ML . * 940002 1 CAPSO 25 8 39 Scott ??? Patent Application Publication Jun . 6 , 2019 Sheet 7 of 42 US 2019 / 0169224 A1 ;2. i i 277.vrrrrrrr . E.L T +7/111 . S 6.5/006%FP 11 " . 117411122 rriii 22 . 2 wir : oots % 0.25%MC/12BAK,PH * .55FFEE i DJ/ VW b& * + 1 . 22 po . 1 :.III 360Bongo . Rrrrr!.1177rrmVrrrrrrr- FIG.7 ww . 5./01%FP . W r . EffectofpHonparticlesize ilF.FE M 22 rirrrrrrr.'-rrrrrrrr1 rrrrrrrr. rururawrrrrrrrrrrrrrrrrrrrr EE . T . T : . -2222, - #xILLIOZY Phosphate0.1%/25 MC10.12%BAK,PH7/01 .-11222222222 CY 122222.:-222222222 1222271:27 rerirrrrrrrrrrrrrrr Hécrittrrrrrr Patent Application Publication Jun . 6 , 2019 Sheet 8 of 42 US 2019 / 0169224 A1 SYYYSYLLTY : . : ' S ' YY 714 * * * * * )cp4000 (MC r+11877- . UFRIR /2142. )cp50 ( MC ! Frrr 177. 427 -. ????????? )cp15 (MC " ??????????????? FIG.8 .us EffectofstabilizerinphaseIIonparticlesize40 )cp45 ( HPMC ooooooo walan errrrr )cp000 , 100( HPMC st *** * * * vreerreen ? ? ?? ? ? ? ? ?- - - ???? ? ? ?? ??? ?????? . ? ? ? ? ? )cp4000 (HPMC $ $ 1999 )microns ( Size Particle Patent Application Publication Jun . 6 , 2019 Sheet 9 of 42 US 2019 / 0169224 A1 30 . X A NXXXXXX MUUTTOV* * * * * * * A LA2222222222222* XXXXXXXXXX 24124222223 * * T22WXXXXXXX* * * * * * * * * * * * * * * 2 1922 * 22222 XLIXL2411 22222222222222222222 . 111 22222 2 2222 LILL21222 , 3" LYWELYYYYYAX122X122X2 LLLLLLLLLLLLLL122222XXXXXX LL22 WAMWWW 11MNIA122 * 1423 1214224242424242242 . 2 * * 3 2323 err/4' 2 ALLY. MALESRh212121 irr-.777 522222222 YUYULA 2 22222 24 12. 2012. 2222222 22292 .44111117/7W Daysat25C FIG.9 2 2222222. 22 2 . 7 * L 012LLLLLLLL 1411172241222222222222012 022 2 1912922222222322 EffectofpHphaseIII(I+II)onparticlesize in1.2rrt' %pH7.5 2441442444919421211211 2X41421194LIKE1922- .? 242212. 2011 222222 * 49 , ' * ' * ' * * ' * ' YYN Y , 34 , 922399 , 99 * .-224/ V ILLE KAT T ' AKLA RE 24X14X 112 22 * * 24 * * * 4III PH5, .-22411 MLXLXX X* . 112 L110 1111111111 11111 . tum 2211. LLLLLLLLS 9222242 11 - 19 ELEO oped Patent Application Publication Jun . 6 , 2019 Sheet 10 of 42 US 2019 /0169224 A1 Batch2 46 14 VANVANKAw doo of 2 -._ PurifiedFluticasonePropionatenanoparticlesdonotdisplay 2345 particlesizegrowthovertime TimeinDays(25degreesC) FIG.10 oooooo 1 *.14 0 AZ CAT TiffSTRANI 900004 microns in Size Particle Patent Application Publication Jun . 6 , 2019 Sheet 11 of 42 US 2019 /0169224 A1 ULAWESI M FIG.12 * * 55F 17 ) d90( Size Particle . .ix .-', . .-' .: FIG.11 : '.- .,'Y: . 26CC .'-: .:;' : 2.80 ,.': '.-: : . : ) microns( Size Particle Patent Application Publication Jun . 6 , 2019 Sheet 12 of 42 US 2019 / 0169224 A1 44444444444444444444444444+. - ', . 14:.siirrr11rrrrrrrrterr+10-, . 2 . FIG.14 .4 Loss+777 Percent ?? TTTTTTTTTTTTTTTTTTTTTTIIIIIIIIIIIIIIIIIIIIIIIIIIIITTEETTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT KOLS FIG.13 WARWOUDERDORPODDARROLDANDO Patent Application Publication Jun . 6 , 2019 Sheet 13 of 42 US 2019 /0169224 A1 0005 Time(hours)attershaking FIG.16 DUHAYASSES ??????????????????? TEEEEE E EEEEEEEEE mrs ????????????????????? .' ????????? wowwwwwwastewwww*ewwwwwwww FIG.15 ???????????????????????????????????????? '. t Patent Application Publication Jun . 6 , 2019 Sheet 14 of 42 US 2019 /0169224 A1 * * * * * * * * * * * * *' . 1 * . * . + - . - - Hours Unr:7417711111/4icrrrr1111111*arrrrrr11142333resrrrid1144472377774684648x2rstmird'AWasy.1244477157714628444 . .- FIG.18 * reserwerowniamnuwe . www.err+* 12"117,112 WHWWU19 060 DOCX Golec13/Bust ??????????????????????????????? Andrews WFP sou AAN VersAV+$ Awards 5 - - 747* FIG.17 C-00211111Hittw1ddiesasswdirasaiwww 11111110V Patent Application Publication Jun . 6 , 2019 Sheet 15 of 42 US 2019 /0169224 A1 fonda 16 . 0275 + 13 .6625 A . 10 .8500 6 . 3500 . 2 . 5650 -- - 14 . 8750 FIG . 19 Patent Application Publication Jun . 6 , 2019 Sheet 16 of 42 US 2019 /0169224 A1 d90 ,Size Particle - . SV 24u.onc . -.enian -.811 nevr.reranian . 1 .nnu-v :-nr - Xogo * ? *. ?. r.- .? 17. 1 Whip - -??? -+ x - * -02.4comocarsrubrerriorea42onee 177 "A. Xo . 2: -renerver.ver:nonvr121vironunr20ronrrnuviscommenun . - - - >www ~r.cznenanros ara. - . 2 S Virk-Orterrrrr":479, .4 2 3 / . 1 reannutry.ove 1 2 .21 1 . W Frror- -11 50Lof0.2%NanosuspensionCanbeProducedin4h ?> FIG.20 : x .1 . Sirenitywar. 13.11 - - kr.orrunnbinrrerrtract4cdrreramordnnv-v rv29:~rry-1032.11> veror.oor)vnnonki-6onnen:roretrneinversrenr

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    97 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us